AI in Medicine News ・ 💊 Drug discovery and clinical trials

Shridevi Institute, US-based Vaxonyx sign MoU for AI-driven cancer and genomic research

The Economic Times · 10/17 12:31 UTC

Shridevi Institute of Medical Sciences in Tumakuru signed an MoU with Vaxonyx LLC to collaborate on AI-enabled bioinformatics and genomic research tailored for Indian populations. They will develop personalized cancer therapies by analyzing individual tumor profiles and explore creating genomic datasets to improve genetic models. They also intend to develop DNA-based vaccine candidates for relevant public health issues.

Read the original (The Economic Times)

See it in the digest → ・ See this issue →